Track the Apollomics Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €41m. The latest transaction was reported on 24 August 2026 (Levée d'options). Among the most active insiders: Chen Hung-Wen. All data is accessible without an account.
15
Insider Decl.
n/a
Thresholds
€7m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
63Σ signal
Buys €7mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,582 shares@ US$15.85100.0% of flowCLASS A ORDINARY SHARESSEC:0001193125-26-161997:0
15 of 15 declarations
Acerca de Apollomics Inc.
Apollomics Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para el cáncer. Cotiza en el NASDAQ bajo el ticker APLM.